Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic Perfusio

Phase 1

• Conditions: Sequelae of PID

• Registration Number: ITMCTR2000002965
• Lead Sponsor: Xianyang Central Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

From February 20,2020 to May 31,2022, females aged 18-55 years, who were diagnosed in the hospital according to the western medicine criteria of sequela of pelvic inflammatory disease and the standards of TCM syndrome of pelvic inflammatory disease of accumulated damp heat according to traditional Chinese medicine.

Exclusion Criteria

1. Patients with severe diseases of heart, liver, kidney and hematopoietic system;
2. Women in pregnancy or to be pregnant in near future or in lactation period;
3. Women who are unable to cooperate, such as those with neurological or mental disorders, or unwilling to cooperate;
4. Those with allergic constitution or multiple drug allergy;
5. Those who have recently used similar drugs for treatment, such as taking drugs with related or antagonistic effects, resulting in difficulty in judging the efficacy of the drugs.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TNF-a;ICAM-1;IL-2;Pelvic sign score;TCM score;IL-6;

Secondary Outcome Measures

Name	Time	Method
TV;age;NG;CA;BV;vagina cleaness;CT;UU;